506239 Sigma-AldrichBupropion Hydrochloride - CAS 31677-93-7 - Calbiochem
Bupropion is a non-selective inhibitor of dopamine and noradrenalin transporters. Also an antagonist for neuronal nicotinic acetylcholine receptors (nAChrs).
More>> Bupropion is a non-selective inhibitor of dopamine and noradrenalin transporters. Also an antagonist for neuronal nicotinic acetylcholine receptors (nAChrs). Less<<Sinónimos: Dopamine and noradrenalin Transporter Inibitor, Bupropion
Productos recomendados
Descripción
Replacement Information |
---|
Tabla espec. clave
CAS # | Empirical Formula |
---|---|
31677-93-7 | C₁₃H₁₈ClNO·HCl |
Precios y disponibilidad
Número de referencia | Disponiblidad | Embalaje | Cant./Env. | Precio | Cantidad | |
---|---|---|---|---|---|---|
5.06239.0001 |
|
Frasco de vidrio | 50 mg |
|
— |
References | |
---|---|
References | Budzynska, B. et al. 2011 Pharmacol. Rep. 63, 71. Dwoskin, P., et al. 2006. CNS Drug Rev. 12, 178. Soroko, F., et al. 1977. J. Pharm. Pharmacol. 29, 769. |
Product Information | |
---|---|
CAS number | 31677-93-7 |
Form | White solid |
Hill Formula | C₁₃H₁₈ClNO·HCl |
Chemical formula | C₁₃H₁₈ClNO·HCl |
Structure formula Image | |
Quality Level | MQ100 |
Applications |
---|
Biological Information | |
---|---|
Primary Target | DAT/NET |
Primary Target K<sub>i</sub> | 1.4 µ |
Purity | ≥99% by HPLC |
Physicochemical Information |
---|
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS |
---|
Safety Information | |
---|---|
R Phrase | R: 22 Harmful if swallowed. |
S Phrase | S: 46 If swallowed, seek medical advice immediately and show this container or label. |
Product Usage Statements |
---|
Packaging Information |
---|
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
Número de referencia | GTIN |
5.06239.0001 | 04055977243185 |
Documentation
Bupropion Hydrochloride - CAS 31677-93-7 - Calbiochem Ficha datos de seguridad (MSDS)
Título |
---|
Referencias bibliográficas
Visión general referencias |
---|
Budzynska, B. et al. 2011 Pharmacol. Rep. 63, 71. Dwoskin, P., et al. 2006. CNS Drug Rev. 12, 178. Soroko, F., et al. 1977. J. Pharm. Pharmacol. 29, 769. |